<noscript id="qeqk6"></noscript>
<noscript id="qeqk6"></noscript>
<center id="qeqk6"></center>
<optgroup id="qeqk6"></optgroup>
<optgroup id="qeqk6"><div id="qeqk6"></div></optgroup><center id="qeqk6"><wbr id="qeqk6"></wbr></center>


Corporate Headquarters

Abcam plc
Discovery Drive
Cambridge Biomedical Campus
F: +44 (0)1223 215 215

Nominated Advisors and Corporate Broker

J.P. Morgan Cazenove
25 Bank Street
Canary Wharf
London E14 5JP

Public Relations Advisors

FTI Consulting
200 Aldersgate
Aldersgate Street
London EC1A 4HD
F: +44 (0)20 3727 1007

Joint Corporate Broker

Numis Securities Limited
The London Stock Exchange Building,
10 Paternoster Square, London,

Note on Unsolicited phone calls

We have been made aware of instances where our shareholders have been called regarding their shareholding by persons offering to purchase their shares. This is what is known as a ‘boiler room scam’. Shareholders are advised to be very wary of any unsolicited advice, offers to buy shares at a discount or offers of free company reports. If you receive such a call, you are advised not to get into a conversation, note the name of the person and firm contacting you and then end the call.

Worried about shareholder fraud? Click here for advice from the Financial Conduct Authority

About Abcam

Abcam is a producer and marketer of high quality protein research tools. These tools enable life scientists to analyse components of living cells at the molecular level which is essential in a wide range of fields including drug discovery, diagnostics, and basic research.

Read more +

Abcam Products

As an innovator in reagents and tools, Abcam offers highly validated binders and assays to address important targets in critical biological pathways.

Read more +

Investor Information

Abcam is listed on the AIM market of the London Stock Exchange under the ticker ABC, and our investors' centre includes a range of information on our company, including our news, financial reports and investor contacts

Read more +

Abcam News

We provide updates on our commercial and financial progress through regular press releases which can be accessed through the Company's media centre.

Read more +